Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Jan;30(1):259–260. doi: 10.1128/jcm.30.1.259-260.1992

Immune reactivity to fractionated Leishmania aethiopica antigens during coinfection with human immunodeficiency virus type 1.

S C Arya
PMCID: PMC265038  PMID: 1734066

Full text

PDF
259

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akuffo H. O., Fehniger T. E., Britton S. Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression. J Immunol. 1988 Oct 1;141(7):2461–2466. [PubMed] [Google Scholar]
  2. Albert J., Fenyö E. M. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers. J Clin Microbiol. 1990 Jul;28(7):1560–1564. doi: 10.1128/jcm.28.7.1560-1564.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alvar J., Verdejo J., Osuna A., Nájera R. Visceral leishmaniasis in a patient seropositive for HIV. Eur J Clin Microbiol. 1987 Oct;6(5):604–606. doi: 10.1007/BF02014266. [DOI] [PubMed] [Google Scholar]
  4. Bryceson A. D. Diffuse cutaneous leishmaniasis in Ethiopia. 3. Immunological studies. IV. Pathogenesis of diffuse cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1970;64(3):380–393. doi: 10.1016/0035-9203(70)90174-4. [DOI] [PubMed] [Google Scholar]
  5. Bryceson A. D. Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease. Trans R Soc Trop Med Hyg. 1969;63(6):708–737. doi: 10.1016/0035-9203(69)90116-3. [DOI] [PubMed] [Google Scholar]
  6. Converse P. J., Fehniger T. E., Ehrnst A., Strannegård O., Britton S. Immune responses to fractionated cytomegalovirus (CMV) antigens after HIV infection. Loss of cellular and humoral reactivity to antigens recognized by HIV-, CMV+ individuals. Clin Exp Immunol. 1990 Dec;82(3):559–566. doi: 10.1111/j.1365-2249.1990.tb05490.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fernández-Guerrero M. L., Aguado J. M., Buzón L., Barros C., Montalbán C., Martín T., Bouza E. Visceral leishmaniasis in immunocompromised hosts. Am J Med. 1987 Dec;83(6):1098–1102. doi: 10.1016/0002-9343(87)90948-x. [DOI] [PubMed] [Google Scholar]
  8. Jeannel D., Tuppin P., Brucker G., Danis M., Gentilini M. Leishmaniasis in France. Lancet. 1989 Sep 30;2(8666):804–804. doi: 10.1016/s0140-6736(89)90868-4. [DOI] [PubMed] [Google Scholar]
  9. Laskay T., Kiessling R., Rinke deWit T. F., Wirth D. F. Generation of species-specific DNA probes for Leishmania aethiopica. Mol Biochem Parasitol. 1991 Feb;44(2):279–286. doi: 10.1016/0166-6851(91)90014-w. [DOI] [PubMed] [Google Scholar]
  10. Laskay T., Mariam H. G., Berhane T. Y., Fehniger T. E., Kiessling R. Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection. J Clin Microbiol. 1991 Apr;29(4):757–763. doi: 10.1128/jcm.29.4.757-763.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Laskay T., Mariam H. G., Berhane T. Y., Fehniger T. E., Kiessling R. Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection. J Clin Microbiol. 1991 Apr;29(4):757–763. doi: 10.1128/jcm.29.4.757-763.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mengistu G., Akuffo H. O., Yemane-Berhan T., Britton S., Fehniger T. E. Serum antibody specificities to Leishmania aethiopica antigens in patients with localized and diffuse cutaneous leishmaniasis. Parasite Immunol. 1990 Sep;12(5):495–507. doi: 10.1111/j.1365-3024.1990.tb00984.x. [DOI] [PubMed] [Google Scholar]
  13. Montalban C., Calleja J. L., Erice A., Laguna F., Clotet B., Podzamczer D., Cobo J., Mallolas J., Yebra M., Gallego A. Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS. J Infect. 1990 Nov;21(3):261–270. doi: 10.1016/0163-4453(90)93933-j. [DOI] [PubMed] [Google Scholar]
  14. Peters B. S., Fish D., Golden R., Evans D. A., Bryceson A. D., Pinching A. J. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q J Med. 1990 Nov;77(283):1101–1111. doi: 10.1093/qjmed/77.2.1101. [DOI] [PubMed] [Google Scholar]
  15. Pisa P., Gennene M., Söder O., Ottenhoff T., Hansson M., Kiessling R. Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis. J Infect Dis. 1990 May;161(5):988–991. doi: 10.1093/infdis/161.5.988. [DOI] [PubMed] [Google Scholar]
  16. Rubin L. A., Nelson D. L. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med. 1990 Oct 15;113(8):619–627. doi: 10.7326/0003-4819-113-8-619. [DOI] [PubMed] [Google Scholar]
  17. Yebra M., Segovia J., Manzano L., Vargas J. A., Bernaldo de Quirós L., Alvar J. Disseminated-to-skin kala-azar and the acquired immunodeficiency syndrome. Ann Intern Med. 1988 Mar;108(3):490–491. doi: 10.7326/0003-4819-108-3-490_2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES